tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Twist Bioscience sees FY24 revenue $285M-$290M, consensus $298.67M

Sees FY24 gross margin 39%-40%. Sees FY24 capital expenditures $20M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on TWST:

Disclaimer & DisclosureReport an Issue

1